Une approche intégrée, non verrouillée, aux essais cliniques virtuels / décentralisés
The New Normal for Clinical Trials: An Enterprise Approach Delivering Integrated Solutions from a Single Partner
Therapeutic Expertise
Rather than starting with technology, our approach begins with an experience in all major clinical indications such as oncology, neurology, CV-MER, iiGM just to name a few. Our strategic planning team will work with your clinical staff to identify key endpoints and help you determine how to structure the visit schedule to reduce patient burden wherever possible.
扩展患者达到加速入学
We break enrollment bottlenecks with our Patient Direct capability combining proprietary databases to focus your enrollment efforts. Our Clinical Trial Connect outreach program uses direct outbound communications to potential patients in appropriate geographies.
围绕患者设计的服务
您的试验是否会受益于方便的家庭移动临床服务，访问>1900Labcorp Patient Service Centers对于样品收集，调整效率和便利性或可穿戴传感器设备的调查产品物流，我们协调患者体验，旨在最大限度地提高患者参与。我们的中央药房服务确保了通过多种途径可供患者提供调查产品，使患者选择自由。通过我们的患者智能网络的实际和预期患者的持续反馈确保我们有最新的见解，以指导我们对您的学习的支持。
An Integrative, In-House DCT Technology Platform
一个真正的DCT体验依赖于一个集成的平台，这个平台提供一个无缝的接口来连接试验的各个方面。我们提供面向患者的应用程序、电视功能和数字工作流，将服务提供商连接到研究者站点。除了提供设备和BYOD支持外，我们还确保了方便性以及法规和协议遵从性。
完整的临床试验解决方案和支持
No matter what biomarker endpoints and safety parameters your therapy needs to monitor, our industry-leading central laboratory and network of specialty and external labs will ensure you get high quality data. Our global logistics team monitors shipments to assure delivery within stability, followed by consistent processing and rapid reporting with a full suite of specimen management and bioprepository services.
.png){kind=icon}
